[{"NetIncomeLoss_2_Q2_USD":-27182.0,"UnrecognizedTaxBenefits_0_Q2_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1_Q2_USD":15800000.0,"SponsorFees_2_Q2_USD":3413.0,"RepaymentsOfRelatedPartyDebt_2_Q2_USD":274059.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":663043930.0,"TemporaryEquitySharesOutstanding_0_Q2_shares":66304393.0,"AssetsCurrent_0_Q2_USD":2467076.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-690000000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"Liabilities_0_Q2_USD":24477867.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":2140755.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":135036.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":692490905.0,"ProceedsFromIssuanceOfPrivatePlacement_2_Q2_USD":15800000.0,"AssetsHeldInTrustNoncurrent_0_Q2_USD":690054727.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_2_Q2_USD":279432.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":27867.0,"Assets_0_Q2_USD":692521803.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"OperatingIncomeLoss_1_Q2_USD":-78496.0,"OperatingIncomeLoss_2_Q2_USD":-81909.0,"NetIncomeLoss_1_Q2_USD":-23769.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"AdditionalPaidInCapital_0_Q2_USD":5030481.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":326321.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":2140755.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":2140755.0,"LiabilitiesCurrent_0_Q2_USD":327867.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-350150.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-32470.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":299521.0,"TemporaryEquityRedemptionPricePerShare_0_Q2_USD":10.0,"ProfitLoss_2_Q2_USD":-27182.0,"OperatingExpenses_2_Q2_USD":81909.0,"OperatingExpenses_1_Q2_USD":78496.0,"PreferredStockSharesAuthorized_0_Q2_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":692521803.0,"PreferredStockValue_0_Q2_USD":0.0,"InvestmentIncomeInterest_2_Q2_USD":54727.0,"InvestmentIncomeInterest_1_Q2_USD":54727.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":677100000.0,"StockholdersEquity_0_Q2_USD":5000006.0,"IncomeTaxExaminationPenaltiesAndInterestAccrued_0_Q2_USD":0.0,"Ticker":"CANO","CIK":"1800682","name":"JAWS ACQUISITION CORP.","OfficialName":"Cano Health Inc. Class A Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"1005497092.0","Country":"nan","Sector":"Health Care","Industry":"Hospital\/Nursing Management","Market":"NYSE","SP500":"nan","filed":"20200813"}]